Best Practices for Management of Newly Diagnosed MS: A Multidisciplinary Team Discussion

Jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Nurse Practitioner Alternatives (NPA) in collaboration with Delaware Media Group and Catamount Medical Education.

 

 

 

To claim credit, please click the button below.

 


 

CE Information

Commercial Support Acknowledgement

This activity is supported by an educational grant from Sanofi Genzyme.

Release date: March 31, 2018
Valid through: March 31, 2019
Estimated Time to Complete Activity: 1 hour

Target Audience
This activity is intended for neurologists, primary care physicians, physiatrists, urologists, nurse practitioners, nurses, physician assistants, rehabilitation specialists, mental health specialists, and other clinicians who manage patients with MS.

Learning Objectives
Upon completing this activity, the participant should be better able to:

  • Define the model of comprehensive care
  • Identify members of the comprehensive care team for patients with MS
  • Discuss barriers to the implementation of comprehensive care in practice
  • Evaluate strategies to address barriers and successfully implement a comprehensive care model in MS
  • Discuss the role of the comprehensive care team in supporting treatment decisions and improving therapy adherence
  • Apply expert recommendations for incorporating a comprehensive care approach to the management of real-life cases

Faculty
Edward Fox, MD, PhD
Medical Director
Multiple Sclerosis Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, TX

Stephanie Agrella, MSN, RN, APRN, ANP-BC, MSCN
Director of Clinical Services
Multiple Sclerosis Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, TX

Frederick Foley, PhD
Professor of Psychology
Ferkauf Graduate School of Psychology
Yeshiva University
Bronx, NY

Tina Warring, MPT
Physical Therapy at Central Texas Neurology Consultants
Round Rock, TX

Accreditation Statements and Credit Designations
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), Delaware Media Group (DMG), and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The CMSC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Alternatives (NPA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NPA designates this enduring material for a maximum of 1 Continuing Nursing Education Credits (0 in the area of pharmacology).

Laurie Scudder, DNP, NP, has served as Nurse Planner for this activity. She has declared no relevant financial relationships.

All other healthcare professionals completing this course will be issued a statement of participation.

Disclosures Policy
In accordance with the ACCME Standards for Commercial Support, the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), Delaware Media Group (DMG), and Catamount Medical Education require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. CMSC, NPA, DMG, and Catamount Medical Education resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC, NPA, DMG, and Catamount Medical Education seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC, NPA, DMG, and Catamount Medical Education are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Faculty Disclosure
Edward Fox, MD, PhD,Program Chair has declared he has served as a consultant for Acorda, Bayer, Biogen, EMD Serono, Genentech, Novartis, Sanofi Genzyme, and Teva. He has also served on the Speakers Bureau for Acorda, Biogen, EMD Serono, Genentech, Novartis, Sanofi Genzyme, and Teva. Dr. Fox has performed contracted research for Acorda, Biogen, Celgene, Chugai, EMD Serono, Genentech Roche, Mallinckrodt, MedDay, Novartis, Opexa, Sanofi Genzyme, Teva, and TG Therapeutics.

Stephanie Agrella, MSN, RN, APRN, ANP-BC, MSCN has declared she has served as consultant for Biogen, Sanofi Genzyme, and Genentech. She has also served on the Speakers Bureau for Acorda, Biogen, EMD Serono, Sanofi Genzyme, Genentech, Teva, and Novartis.

Frederick Foley, PhD has declared he has served on the Speakers Bureau for Sanofi Genzyme.

Tina Warring, MPT has declared no relevant financial relationships.

Activity Staff Disclosures
The planners, reviewers, editors, staff, or other members at CMSC who control content have declared no relevant financial relationships.
Laurie Scudder, DNP, NP, has served as Nurse Planner for this activity. She has declared no relevant financial relationships.
The planners, reviewers, editors, staff, CME committee, or other members at DMG who control content have declared no relevant financial relationships.
The planners, reviewers, editors, staff, CME committee, or other members at Catamount Medical Education who control content have declared no relevant financial relationships.

Media: Print

Method of Participation / How to Receive Credit
There are no fees for participating in and receiving credit for this activity. During the period March 31, 2018 through March 31, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the activity evaluation, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.

Credit documentation/reporting: If you are requesting AMA PRA Category 1 Credit(s)™, nursing credit(s), or a certificate of participation, your CME/CE certificate will be available for download.

Disclosure of Unlabeled Use
CMSC, NPA, DMG, and Catamount Medical Education require CME faculty to disclose when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. CMSC, NPA, DMG, and Catamount Medical Education do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer
CMSC, NPA, DMG, and Catamount Medical Education present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC, NPA, DMG, and Catamount Medical Education, and the commercial supporters assume no liability for the information herein.

Privacy Policy
Catamount Medical Education, LLC, respects your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CME activities viewed and the post-test and evaluation results for CME/CNE credit. This information is provided to activity collaborators for the purposes of CME/CNE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information.

Contact Information
If you have questions about this CME activity, please contact Catamount Medical Education at 860-661-4159 or info@catmeded.com.